Category Archives: BioInformatics

Summary: | Photo Credit: handout_e_mailS Subbiah, Vice-Chancellor of Alagappa University, said the University proposed to establish Indian Bioinformatics and Drug Discovery Society (IBDDS) for dissemination of scientific knowledge and provide advanced bioinformatics training. They would also throw light on the importance of using bioinformatics tools in human healthcare system. Veejendra K Yadav of IIT-Kanpur, in his thematic address, said a deep knowledge of chemistry was required for the development of drug design by using several combinations via biological interactions. Thirteen scientists from various prestigious institutions in the country were giving give lectures about the computational methods in the four-day workshop. Congratulating the Department of bioinformatics, headed by J. Jayakanthan, for its exemplary research activities, he said computer-aided drug discovery would help reduce the constraints caused by time and cost. THE WAY AHEAD: S. Subbiah, Vice-Chancellor of Alagappa University, speaking at a sysmposium in Karaikudi on Tuesday. | Photo Credit: handout_e_mail S Subbiah, Vice-Chancellor of Alagappa University, said the University proposed to establish Indian Bioinformatics and Drug Discovery Society (IBDDS) for dissemination of scientific knowledge and provide advanced bioinformatics training. The society will serve as a platform for dissemination of scientific knowledge and function as a central hub between bioinformatics, biological … Continue reading →

February 14, 2017 Biological experiments are generating increasingly large and complex sets of data. This has made it difficult to reproduce experiments at other research laboratories in order to confirm or refute the results. The difficulty lies not only in the complexity of the data, but also in the elaborate computer programmes and systems needed to analyse them. Scientists from the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg have now developed a new bioinformatics tool that will make the analysis of biological and biomedical experiments more transparent and reproducible. The tool was developed under the direction of Prof. Paul Wilmes, head of the LCSB group Eco-Systems Biology, in close cooperation with the LCSB Bioinformatics Core. A paper describing the tool has been published in the highly ranked open access journal Genome Biology. The new bioinformatics tool, called IMP, is also available to researchers online (r3lab.uni.lu/web/imp/). Biological and biomedical research is being inundated with a flood of data as new studies delve into increasingly complex subjects like the entire microbiome of the gut using faster automated techniques allowing so-called high-throughput experiments. Experiments that not long ago had to be carried out laboriously by hand can now be … Continue reading →

Share The latest market report published by Credence Research, Inc.GlobalBioinformatics Market Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 2024,thebioinformatics market was valued at USD 8,580.0 Mn in 2015, and is expected to reach USD 38,614.0 Mn by 2024, expanding at a CAGR of 20.3% from 2016 to 2024. Market Insights The key applications of bioinformatics comprises in gene sequence analysis, gene and protein expression analysis, gene regulation analysis, genome annotation, and mutation analysis. Bioinformatics plays key role in research optimization via effective data management during and after clinical trials. The factor assisting its market growth throughout the forecast period is existence of huge government funding and market introduction of technological advancements in the fields of genomics and proteomics. The market experts suggested that, market growth of bioinformatics has been also driven by the companies that express a need to adopt more cost-efficient and prolific methods to commercialize proprietary information. The suppliers operating in this market are expected to provide products or services such as complete integration of data infrastructure including data sharing facility, data security, data searching, proposed customization and data analysis. Browse the fullreport Bioinformatics Market Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 2024 report athttp://www.credenceresearch.com/report/bioinformatics-market Applications … Continue reading →

This press release was orginally distributed by SBWire Albany, NY -- (SBWIRE) -- 02/10/2017 -- The global bioinformatics market is expected to be valued at US$9.1 bn by the end of 2018. It is shown to expand at a positive CAGR in a research report released by Transparency Market Research. The report, titled "Global Bioinformatics Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020," talks about the key factors that have and will influence this market for the given forecast period. Browse Full Global Bioinformatics Market (By Platforms, Tools and Services and By Applications: Preventive Medicine, Molecular Medicine, Gene Therapy Drug Development and Others) - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 Report at @ http://www.transparencymarketresearch.com/bioinformatics-market.html Get Free Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=656 Bioinformatics is the management of information generated from R&D efforts combined under biopharmaceuticals, life sciences, and biotechnology. It applies computer technology to compile and store the data, which can later be analyzed and integrated with other biological and genetic data. The key reason for the foundation as well as the proliferation of the global bioinformatics market is the massive amounts of data generated in the Human Genome Project. This data … Continue reading →

Submit the press release The global bioinformatics market is expected to be valued at US$9.1 bn by the end of 2018. It is shown to expand at a positive CAGR in a research report released by Transparency Market Research. The report, titled Global Bioinformatics Market Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 2020, talks about the key factors that have and will influence this market for the given forecast period. Browse Full Global Bioinformatics Market (By Platforms, Tools and Services and By Applications: Preventive Medicine, Molecular Medicine, Gene Therapy Drug Development and Others) Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 2020 Report at @ http://www.transparencymarketresearch.com/bioinformatics-market. Get Free Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag Bioinformatics is the management of information generated from R&D efforts combined under biopharmaceuticals, life sciences, and biotechnology. It applies computer technology to compile and store the data, which can later be analyzed and integrated with other biological and genetic data. The key reason for the foundation as well as the proliferation of the global bioinformatics market is the massive amounts of data generated in the Human Genome Project. This data was made public and gave rise to the need for bioinformatics. The current growth rate … Continue reading →

Submit the press release The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications. Bioinformatics involves the development and application of novel informatics techniques in the field of biology. It improves the methods of storing, organizing, retrieving and analyzing biological data. Major activity in bioinformatics is to develop software tools in order to generate useful biological knowledge database. In molecular biology, bioinformatics techniques such as signal processing allow extraction of useful results from large amount of raw data. In the field of genetics it helps in sequencing, annotating genomes and to observe mutations. Bioinformatics study acts a biological literature and developmental data bank for biology related data. Download Exclusive Global Strategic Business Report: http://www.transparencymarketresearch.com/sample/sample.php?flag Similarly, biomedical informatics is an emerging discipline which defines the study of inventions and implementation of structures, algorithms to improve communication, understanding and managing the medical … Continue reading →

The European Bioinformatics Institute (EBI), part ofthe European Molecular Biology Laboratory (EMBL), has announced it's using Red Hat's OpenStack Platform to drive forward its collaborative research project, known as the Embassy Cloud. The project's aim is to collaborate with researchers worldwide on life science experiments to find the answers to many worldwide problems, such as pan-cancer analysis. EMBL-EBI needed to find a platform that could scale dramatically to respond to the greater data demands it was experiencing. The organisation was previously using VMwares vCloud, but it needed a more responsive solution and because the EBI has already been using Red Hat Enterprise Linux, it decided to look at other solutions Red Hat offered. "Many global research collaborations would not be possible without the functionality of Embassy Cloud,"Steven Newhouse, head of Technical Services at EMBL-EBI said. "We are now using the Red Hat OpenStack Platform to support these collaborations - it has the flexibility and scalability needed to allow people working on different projects, in different locations, to access the information they need, as and when they need it." As well as being an open standard in the research community, EBI knew Red Hat's OpenStack could deliver the scalable, flexible cloud … Continue reading →

Submit the press release Bioinformatics involves the development and application of novel informatics techniques in the field of biology. It improves the methods of storing, organizing, retrieving and analyzing biological data. Major activity in bioinformatics is to develop software tools in order to generate useful biological knowledge database. In molecular biology, bioinformatics techniques such as signal processing allow extraction of useful results from large amount of raw data. In the field of genetics it helps in sequencing, annotating genomes and to observe mutations. Bioinformatics study acts a biological literature and developmental data bank for biology related data. Request Sample of Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag Similarly, biomedical informatics is an emerging discipline which defines the study of inventions and implementation of structures, algorithms to improve communication, understanding and managing the medical information. The National Center for Toxicological Research (NCTR) conducts research in bioinformatics and chemo informatics. The bioinformatics tools were created for analysis and integration of genomics, proteomics, metabolomics datasets and transcriptomics. The growth of global medical bioinformatics market is driven by increasing initiatives and funding, use of bioinformatics in drug discovery and biomarkers. The market is expected to offer opportunities with the introduction and adoption of upcoming technologies such as cloud … Continue reading →

Posted Jan. 31, 2017 at 9:45 a.m. Published: 2017-01-31 09:45:00 Updated: 2017-01-31 09:45:00 By Wire reports Research Triangle Park, N.C. In news from Triangle and N.C. tech as well as life science companies: The details: From Syngenta: Syngenta and the AI for Good Foundation have partnered to launch the Syngenta AI Challenge, a new international competition focused on leveraging Artificial Intelligence (AI) tools for use in seed breeding. The competition is accepting submissions from applicants who are ready to put their programming skills to the test for the chance to win $7,500. "This new competition will give entrants the chance to use their talents to take on the extraordinary complexity of seed genetic data," said Joseph Byrum, Ph.D., MBA, PMP and senior R&D strategic marketing executive with Syngenta. "In the face of a rising global population, we need to grow plants that can adapt and thrive in changing conditions especially as vital resources like water and land are finite. The Syngenta AI Challenge is about creating models that can help solve this puzzle and ensure world food security." The competition challenges participants to develop a model that can be used to analyze large amounts of seed data more effectively, ultimately … Continue reading →

The European Bioinformatics Institute (EMBL-EBI) is a centre for research and services in bioinformatics, and is part of European Molecular Biology Laboratory (EMBL). The roots of the EMBL-EBI lie in the EMBL Nucleotide Sequence Data Library[3][4] (now known as EMBL-Bank), which was established in 1980 at the EMBL laboratories in Heidelberg, Germany and was the world's first nucleotide sequence database.[5] The original goal was to establish a central computer database of DNA sequences, to supplement sequences submitted to journals. What began as a modest task of abstracting information from literature soon became a major database activity with direct electronic submissions of data and the need for highly skilled informatics staff. The task grew in scale with the start of the genome projects, and grew in visibility as the data became relevant to research in the commercial sector. It soon became apparent that the EMBL Nucleotide Sequence Data Library needed better financial security to ensure its long-term viability and to cope with the sheer scale of the task. There was also a need for research and development to provide services, to collaborate with global partners to support the project, and to provide assistance to industry. To this end, in 1992, the … Continue reading →